newsfilter
← Latest News
GlobeNewswire·

Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings

NESS ZIONA, Israel, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ:SLGL) ("Sol-Gel" or the "Company"), a dermatology company with FDA approvals for EPSOLAY® and TWYNEO®, two innovative